日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Interleukin-2 activity can be fine tuned with engineered receptor signaling clamps

可以通过工程化的受体信号钳来微调白细胞介素-2 的活性

Suman Mitra, Aaron M Ring, Shoba Amarnath, Jamie B Spangler, Peng Li, Wei Ju, Suzanne Fischer, Jangsuk Oh, Rosanne Spolski, Kipp Weiskopf, Holbrook Kohrt, Jason E Foley, Sumati Rajagopalan, Eric O Long, Daniel H Fowler, Thomas A Waldmann, K Christopher Garcia, Warren J Leonard

Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivo

骨髓间充质基质细胞利用嘌呤信号在体内耐受人类 Th1 细胞

Shoba Amarnath, Jason E Foley, Don E Farthing, Ronald E Gress, Arian Laurence, Michael A Eckhaus, Jean-Yves Métais, Jeremy J Rose, Frances T Hakim, Tania C Felizardo, Austin V Cheng, Pamela G Robey, David E Stroncek, Marianna Sabatino, Minoo Battiwalla, Sawa Ito, Daniel H Fowler, Austin J Barrett

Differential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cells

第一代与第二代雷帕霉素耐药同种异体T细胞的差异基因表达谱

Luciano Castiello, Miriam Mossoba, Antonella Viterbo, Marianna Sabatino, Vicki Fellowes, Jason E Foley, Matthew Winterton, David C Halverson, Sara Civini, Ping Jin, Daniel H Fowler, David F Stroncek

Rapamycin generates anti-apoptotic human Th1/Tc1 cells via autophagy for induction of xenogeneic GVHD

雷帕霉素通过自噬诱导产生抗凋亡的人类Th1/Tc1细胞,从而诱导异种移植物抗宿主病(GVHD)。

Shoba Amarnath ,Francis A Flomerfelt, Carliann M Costanzo, Jason E Foley, Jacopo Mariotti, Daniel M Konecki, Anu Gangopadhyay, Michael Eckhaus, Susan Wong, Bruce L Levine, Carl H June, Daniel H Fowler

Potent induction of B- and T-cell immunity against human carcinoembryonic antigen-expressing tumors in human carcinoembryonic antigen transgenic mice mediated by direct lentivector injection

直接慢病毒载体注射可有效诱导人类癌胚抗原转基因小鼠对表达人类癌胚抗原的肿瘤产生 B 细胞和 T 细胞免疫

Severine Loisel-Meyer, Tania Felizardo, Jacopo Mariotti, Miriam E Mossoba, Jason E Foley, Robert Kammerer, Nobuo Mizue, Robert Keefe, J Andrea McCart, Wolfgang Zimmermann, Boro Dropulic, Daniel H Fowler, Jeffrey A Medin

Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells

已确诊的急性移植物抗宿主病的 Th2 细胞疗法需要 IL-4 和 IL-10,并被 IL-2 或宿主型抗原呈递细胞所消除

Jason E Foley, Jacopo Mariotti, Kaitlyn Ryan, Michael Eckhaus, Daniel H Fowler